Periprosthetic fracture is an uncommon but significant complication of total knee replacement (TKR). A wide range in incidence of fracture after TKR---from 0.3% to 2.5%---has been reported ([@CIT0001], [@CIT0021], [@CIT0023]). The consequences of periprosthetic fracture after a TKR in the elderly are devastating, including increased morbidity and mortality and the need for revision surgery ([@CIT0005], [@CIT0013], [@CIT0019]). Most studies that have assessed the incidence of periprosthetic fractures were performed 20--30 years ago ([@CIT0010], [@CIT0009], [@CIT0013]). Due to changing demographics of patients receiving TKR ([@CIT0008], [@CIT0014]), the risk of periprosthetic fracture may be changing. The indications of TKR have expanded dramatically in the last 2 decades to include much younger ([@CIT0014]) and older patients ([@CIT0020]), both of whom may have a higher risk of having periprosthetic fractures. More recent estimates are needed to better inform patients and surgeons about this risk.

Most of the previous studies that examined risk factors for periprosthetic fractures after TKR did not perform multivariable-adjusted statistical analyses, and they had small number of cases and relatively short duration of follow-up. Several risk factors for periprosthetic fractures were identified, including osteoporosis ([@CIT0021], [@CIT0002]), inflammatory arthritis ([@CIT0021], [@CIT0016], [@CIT0017]), corticosteroid use ([@CIT0022]), older age ([@CIT0019]), female gender ([@CIT0004], [@CIT0002], [@CIT0019]), and previous revision arthroplasty ([@CIT0021], [@CIT0016], [@CIT0019], ). Recent reviews have summarized these findings ([@CIT0023], [@CIT0018]). Most previous studies focused on primary TKRs, and therefore little is known about fractures after revision TKRs. These studies did not examine modifiable factors such as body mass index (BMI) and comorbidity.

The objective of this study was to: (1) provide estimates of periprosthetic fracture after primary and revision TKR, and (2) to determine whether patient demographic characteristics (age and sex) and clinical characteristics (such as comorbidity and BMI) were independently associated with the risk of periprosthetic fracture.

Patients and methods {#ss1}
====================

Selection of study cohort {#ss2}
-------------------------

We used data prospectively collected in a large institutional registry to perform analyses of periprosthetic fractures after primary and revision TKR. The Mayo Clinic Total Joint Registry has prospectively collected preoperative and postoperative follow-up data on all patients who underwent arthroplasty at Mayo Clinic, Rochester, since the first hip and knee arthroplasty were performed in 1969 and 1971, respectively ([@CIT0003]). All patients are prospectively followed with clinical follow-up visits, and in those who do not return, with mailed questionnaires and telephone interviews administered by trained, dedicated Total Joint Registry staff. The data are stored electronically in a database. Complications including but not limited to fracture, infection, surgical procedures, and mortality are registered. Medical records including radiographs and operative reports are obtained from outside institutions to confirm complications such as fractures. From this registry, we selected patients who underwent primary or revision TKR between 1989 and 2008. This time period was chosen to provide a large enough sample, to be more representative of recent data, and to allow inclusion of important variables such as BMI and ASA class in the analyses, which were available in electronic datasets from 1989. This study was approved by the Mayo Clinic Institutional Review Board and all investigations were conducted in conformity with ethical principles of research.

Study outcome and predictors {#ss3}
----------------------------

The study outcome was the occurrence of postoperative periprosthetic fracture from postoperative day 1 or later in patients with primary or revision TKR. This excluded intraoperative fractures or fractures on the day of surgery, which are difficult to differentiate from each other definitively, since the exact time of each fracture is not captured in the registry. Intraoperative fractures were not of interest in this study.

We considered several important potential risk factors for postoperative periprosthetic fractures after primary or revision TKR. The demographic characteristics included sex and age, categorized as previously described (≤ 60, 61--70, 71--80 and \> 80 years) ([@CIT0025], 2011, [@CIT0024]). Clinical variables included BMI, comorbidity assessed with the Deyo-Charlson index ([@CIT0011]), and the American Society of Anesthesiology (ASA) Physical Status score ([@CIT0012]). BMI was categorized as \< 25, 25--29.9 (overweight), 30--39.9 (obese), or ≥ 40 (morbidly obese), as previously described ([@CIT0026]) and as in the WHO classification ([@CIT0028]). Comorbidity was assessed with the Deyo-Charlson index, a validated measure of comorbidity consisting of a weighted scale of 17 comorbidities (including cardiac disease, pulmonary disease, renal disease, hepatic disease, diabetes, cancer, hemiplegia, and HIV), expressed as a summative score ([@CIT0006], [@CIT0007]). ASA score, categorized as class I--II or III--IV, is a validated measure of perioperative mortality and immediate postoperative morbidity ([@CIT0012], [@CIT0027]). Implant fixation was categorized as cemented implant (including hybrid) or uncemented implant. Operative diagnosis was categorized as follows: (a) osteoarthritis, rheumatoid/inflammatory arthritis, avascular necrosis, or other, for primary TKR; and (b) loosening/wear/osteolysis, dislocation/bone fracture or prosthesis fracture/instability/non-union (with non-union being defined as non-united fractures, such as non-union of a femoral head fracture, proximal or distal femoral fracture, or patellar fracture, including periprosthetic fractures), failed previous arthroplasty with components removed/infection, for revision TKR. The latter group included patients with previous fractures with components removed with failed previous internal fixation or previous athrodesis and patients with patellectomy and osteotomy or with infection.

Statistics {#ss4}
----------

We performed separate analyses for primary and revision TKR. Using univariate Cox regression analyses, all predictor variables were assessed for association with the hazard of periprosthetic fracture after TKR. All variables significantly associated in univariate regression (p \< 0.05) were entered into a backward-selection multivariable-adjusted Cox regression model. The proportional hazard assumption held true in the multivariable models for primary and revision TKR. The models accounted for correlated data due to bilateral TKR in the same patient. The models account for correlated joints within the same patient. We used the covsandwich (aggregate) option using the id statement to account for correlated joints ([@CIT0015]). Censoring was at the occurrence of the postoperative periprosthetic fracture or death, or loss to follow-up. Hazard ratios (HRs) are given with 95% confidence intervals (CIs). We also performed survival analyses using Kaplan-Meier curves, for primary and revision TKR cohorts separately.

Results {#ss5}
=======

Characteristics of study cohort {#ss6}
-------------------------------

Between 1989 and 2008, 12,914 patients underwent 17,633 primary TKRs at the Mayo Clinic. Mean age was 68 years; 9% of the patients were older than 80 years and 81% were older than 60 years. 55% of the patients were women. 27% had bilateral TKR and mean follow-up time was 6.3 years ([Table 1](#T1){ref-type="table"}). 44% were ASA class 3 or higher and 21% had a Deyo-Charlson index of 3 or more. Osteoarthritis was the underlying diagnosis in 93% of patients, and 91% had cemented or hybrid implant fixation.

###### 

Demographic features of study cohort as mean (SD) or n (%), unless specified otherwise

                                               Primary TKA      Revision TKA
  -------------------------------------------- ---------------- ----------------
  Mean follow-up, years (SD)                   6.3 (4.7)        5.1 (4.2)
  Female                                       9,781 (55%)      2,084 (51%)
  Bilateral                                    4,719 (27%)      804 (20%)
  Mean age at surgery, years (SD)              68.4 (10.0)      67.9 (11.3)
  Age category                                                  
   ≤ 60 years                                  3,352 (19%)      915 (22.4%)
   61--70 years                                6,206 (35.2%)    1,286 (31.4%)
   71--80 years                                6,493 (36.8%)    1,476 (36.1%)
   \>80 years                                  1,582 (9%)       413 (10.1%)
  Body mass index (BMI), kg/m^2^ (SD)          31.2 (6.2)       31.1 (6.5)
  BMI category, kg/m^2^                                         
   Missing                                     67 (0.4%)        36 (0.9%)
   Normal, \< 25.0                             2,362 (13.4%)    584 (14.4%)
   Overweight, 25--29.9                        5,961 (33.9%)    1,363 (33.6%)
   Obese, 30--39.9                             7,710 (43.9%)    1,731 (42.7%)
   Morbidly obese, ≥ 40.0                      1,533 (8.7%)     376 (9.3%)
  ASA class **[^a^](#T1-N1){ref-type="fn"}**                    
   1                                           291 (1.7%)       50 (1.2%)
   2                                           9,614 (54.7%)    1,869 (45.8%)
   3                                           7,544 (42.9%)    2,098 (51.4%)
   4                                           117 (0.7%)       61 (1.5%)
  Mean Deyo-Charlson index (SD)                1.5 (2.2)        1.3 (2.1)
  Deyo-Charlson index                                           
   0                                           7,985 (45.3%)    2,086 (51%)
   1                                           3,598 (20.4%)    836 (20.4%)
   2                                           2,291 (13%)      470 (11.5%)
   3+                                          3,759 (21.3%)    698 (17.1%)
  Previous cardiac event                                        
   No                                          14,404 (81.7%)   3,490 (85.3%)
   Yes                                         3,229 (18.3%)    600 (14.7%)
  Previous thromboembolic event                                 
   No                                          16,869 (95.7%)   3,873 (94.7%)
   Yes                                         764 (4.3%)       217 (5.3%)
  Operative diagnosis (primary TKR)                             
   Osteoarthritis                              16,372 (92.8%)   
   Rheumatoid arthritis                        657 (3.7%)       
   Avascular necrosis                          152 (0.8%)       
   Other **[^b^](#T1-N2){ref-type="fn"}**      604 (3.4%)       
  Operative diagnosis (revision TKR)                            
   Failure: loose/wear/osteolysis                               2,154 (52.7%)
   Failure: previous surgery with                               
   components removed                                           801 (19.6%)
   Failure: fracture, dislocation                               877 (21.4%)
   Failure: non-union                                           27 (0.7%)
   Failure: infection                                           228 (5.6%)
  Implant fixation                                              Not applicable
   Uncemented                                  1,555 (8.8%)     
   Cemented or hybrid\*                        16,078 (91.2%)   

**^a^** American Society of Anesthesiologists (ASA) score was missing in 67 (0.4%) of primary TKR patients and 12 (0.3%) of revision TKR patients

**^b^** Other diagnoses for primary TKA included: genu varum, genu valgum, hemophilia, Paget's disease, failed previous disease including arthrodesis, failed previous osteotomy, failed previous patellectomy, Chacot arthropathy, chondromalacia, pigmented villonodular synovitis; data on operative diagnosis were missing for 3 patients with revision TKR.

The revision study cohort consisted of 3,286 patients who underwent 4,090 revision TKRs at the Mayo Clinic from 1989 through 2008. Mean age was also 68 years, 51% were women, 20% had bilateral TKR, and mean follow-up time was 5.1 years ([Table 1](#T1){ref-type="table"}). 10% of patients were older than 80 years and 78% were older than 60 years. ASA was class I--II in 47%; 12% had a Deyo-Charlson index of 2 and 17% had a Deyo-Charlson index of 3 or more. The most frequent underlying diagnosis was loosening, wear, or osteolysis (53%), followed by fracture/dislocation (21%) and failed previous surgery with components removed (20%).

Cumulative incidence of postoperative periprosthetic fracture {#ss7}
-------------------------------------------------------------

The cumulative incidence of postoperative periprosthetic fracture on or after postoperative day 1 after primary TKR was 1.1% (188/17,633 patients) and it was 2.5% after revision TKR (104/4,090 patients). 74% of fractures occurred 1 year or more after primary and revision TKR (Appendix 1).

Risk factors for postoperative periprosthetic fractures after primary TKR {#ss8}
-------------------------------------------------------------------------

Age was the only factor that was significantly associated with higher risk of postoperative periprosthetic fracture after primary TKR in univariate analysis ([Table 2](#T2){ref-type="table"}). Higher Deyo-Charlson comorbidity class showed a non-significant association with fracture after primary TKR.

###### 

Univariate and multivariable-adjusted risk of periprosthetic fracture following primary total knee arthroplasty

                             Total    Periprosthetic fractures   Univariate hazard   Multivariable **[^a^](#T2-N1){ref-type="fn"}** model 1 hazard   Multivariable **[^b^](#T2-N2){ref-type="fn"}** model 2 hazard   Multivariable **[^c^](#T2-N3){ref-type="fn"}** model 3 hazard
  -------------------------- -------- -------------------------- ------------------- --------------------------------------------------------------- --------------------------------------------------------------- ---------------------------------------------------------------
  Sex                                                            p = 0.2                                                                                                                                             p = 0.2
   Male                      7,852    74 (1%)                    1.00 (ref)                                                                                                                                          1.00 (ref)
   Female                    9,781    114 (1%)                   1.23 (0.91--1.64)                                                                                                                                   1.24 (0.92--1.68)
  Age category                                                   p \< 0.001          p \< 0.001                                                      p = 0.001                                                       p = 0.002
   ≤ 60                      3,352    52 (2%)                    1.00 (ref)          1.00 (ref)                                                      1.00 (ref)                                                      1.00 (ref)
   61--70                    6,206    59 (1%)                    0.52 (0.36--0.76)   0.51 (0.35--0.74)                                               0.52 (0.36--0.76)                                               0.52 (0.36--0.77)
   71--80                    6,493    58 (1%)                    0.56 (0.38--0.81)   0.55 (0.38--0.80)                                               0.55 (0.37--0.80)                                               0.54 (0.36--0.80)
   \> 80                     1,582    19 (1%)                    0.97 (0.57--1.65)   0.97 (0.57--1.64)                                               0.94 (0.55--1.61)                                               0.90 (0.52--1.58)
  Body mass index, kg/m^2^                                       p = 0.4                                                                                                                                             p = 0.5
   Normal, \< 25.0           2,362    29 (1%)                    1.00 (ref)                                                                                                                                          1.00 (ref)
   Overweight, 25--29.9      5,961    75 (1%)                    0.77 (0.50--1.18)                                                                                                                                   1.09 (0.70--1.68)
   Obese, 30--39.9           7,710    71 (1%)                    0.94 (0.49--1.81)                                                                                                                                   0.83 (0.54--1.30)
   Morbidly obese, ≥ 40.0    1,533    13 (1%)                    0.99 (0.64--1.51)                                                                                                                                   0.87 (0.44--1.71)
  Deyo-Charlson index                                            p = 0.06                                                                            p = 0.05                                                        p = 0.04
   0                         7,985    75 (1%)                    1.00 (ref)                                                                          1.00 (ref)                                                      1.00 (ref)
   1                         3,598    42 (1%)                    1.27 (0.87--1.86)                                                                   1.21 (0.82--1.79)                                               1.22 (0.82--1.81)
   2                         2,291    25 (1%)                    1.35 (0.86--2.13)                                                                   1.39 (0.88--2.19)                                               1.42 (0.90--2.26)
   3+                        3,759    46 (1%)                    1.66 (1.15--2.40)                                                                   1.68 (1.16--2.44)                                               1.75 (1.18--2.59)
  Previous cardiac event                                         p = 0.2                                                                                                                                             p = 0.07
   No                        14,404   166 (1%)                   1.00 (ref)                                                                                                                                          1.00 (ref)
   Yes                       3,229    22 (1%)                    0.76 (0.49--1.19)                                                                                                                                   0.65 (0.40--1.04)
  Previous thromboembolism                                       p = 0.6                                                                                                                                             p = 0.6
   No                        16,869   181 (1%)                   1.00 (ref)                                                                                                                                          1.00 (ref)
   Yes                       764      7 (1%)                     1.21 (0.57--2.58)                                                                                                                                   1.20 (0.56--2.57)
  Operative diagnosis                                            p = 0.2                                                                             p = 0.2                                                         p = 0.3
   Osteoarthritis            16,372   159 (1%)                   1.00 (ref)                                                                          1.00 (ref)                                                      1.00 (ref)
   Rheumatoid arthritis      657      13 (2%)                    1.13 (0.28--4.57)                                                                   1.16 (0.64--2.11)                                               1.01 (0.55--1.87)
   Avascular necrosis        152      2 (1%)                     1.73 (0.99--3.01)                                                                   --                                                              --
   Other                     452      14 (3%)                    1.51 (0.85--2.65)                                                                   1.57 (0.94--2.65)                                               1.55 (0.92--2.61)
  Implant fixation                                               p = 0.3                                                                                                                                             p = 0.6
   Uncemented                1555     14 (1%)                    1.00 (ref)                                                                                                                                          1.00 (ref)
   Cemented or hybrid        16,078   174 (1%)                   0.76 (0.44--1.31)                                                                                                                                   0.87 (0.50--1.51)
  ASA class                                                      p = 0.5                                                                                                                                             p = 0.6
   1                         291      5 (2%)                     1.00 (ref)                                                                                                                                          1.00 (ref)
   2                         9,614    97 (1%)                    0.64 (0.26--1.58)                                                                                                                                   0.75 (0.30--1.86)
   3                         7,544    83 (1%)                    0.79 (0.32--1.94)                                                                                                                                   0.93 (0.36--2.37)
   4                         117      1 (1%)                     0.66 (0.08--5.68)                                                                                                                                   0.80 (0.09--6.99)

**^a^** Multivariable model 1 was a Cox regression model that considered all significant variables from the univariate analyses with a p-value of \< 0.05--and retained only those significantly associated in the multivariable model by using a backward-selection process; the c-statistic of the multivariable model was 0.58.

**^b^**Multivariable model 2 was a Cox regression model obtained by retaining all variables from the univariate analyses with a p-value of \< 0.20 and forcing all of them in the model; the c-statistic of the multivariable model was 0.61.

**^c^**Multivariable model 3 was a Cox regression model obtained by retaining all variables from the univariate analyses regardless of p-value and forcing all of them in the model; the c-statistic of the multivariable model was 0.62.

ASA: American Society of Anesthesiologists; CI: confidence interval; ref: reference category.

In multivariable-adjusted analyses, only age was significantly associated with risk of postoperative periprosthetic fracture after primary TKR. Age categories 61--70 and 71--80 were both associated with a 40--50% lower risk compared to age 60 years or younger, while age \> 80 years was not statistically significantly different from age ≤ 60 years in this respect ([Table 2](#T2){ref-type="table"}). We performed additional post-hoc testing of whether age \> 80 years was associated with higher fracture risk than ages 61--70 and 71--80; we obtained hazard ratios of 1.9 (CI: 1.1--3.1) and 1.7 (CI: 1.0--2.9), which were both statistically significant with p-values of 0.02 and 0.04, respectively. Sensitivity analysis that adjusted for length of FU by testing the term "age\*length of follow-up" revealed that length of FU did not significantly affect the significant relationship between age and postoperative periprosthetic fractures after primary TKR.

Risk factors for postoperative periprosthetic fracture after revision TKR {#ss9}
-------------------------------------------------------------------------

In univariate analyses, we found that operative diagnosis and higher comorbidity, assessed with Deyo-Charlson index, were significantly associated with the risk of postoperative periprosthetic fracture ([Table 3](#T3){ref-type="table"}).

###### 

Multivariable-adjusted hazard of periprosthetic fracture after revision total knee arthroplasty

                                    Total   Periprosthetic fractures   Univariate hazard   Multivariable **[^a^](#T3-N1){ref-type="fn"}** model 1 hazard   Multivariable **[^b^](#T3-N2){ref-type="fn"}** model 2 hazard   Multivariable **[^c^](#T3-N3){ref-type="fn"}** model 3 hazard
  --------------------------------- ------- -------------------------- ------------------- --------------------------------------------------------------- --------------------------------------------------------------- ---------------------------------------------------------------
  Sex                                                                  p= 0.09                                                                             p = 0.06                                                        p = 0.06
   Male                             2,006   42 (2%)                    1.00 (ref)                                                                          1.00 (ref)                                                      1.00 (ref)
   Female                           2,084   62 (3%)                    1.40 (0.9--2.07)                                                                    1.47 (0.98--2.21)                                               1.48 (0.99--2.22)
  Age category                                                         p = 0.3                                                                                                                                             p = 0.3
   ≤60                              915     27 (3%)                    1.00 (ref)                                                                                                                                          1.00 (ref)
   61-70                            1,286   38 (3%)                    0.84 (0.51--1.38)                                                                                                                                   0.82 (0.49--1.36)
   71-80                            1,476   34 (2%)                    0.68 (0.41--1.14)                                                                                                                                   0.68 (0.40--1.16)
   \>80                             413     5 (1%)                     0.44 (0.17--1.15)                                                                                                                                   0.44 (0.16--1.18)
  Body mass index, kg/m^2^                                             p = 0.1                                                                             p = 0.2                                                         p = 0.4
   Normal, \< 25.0                  584     16 (3%)                    1.00 (ref)                                                                          1.00 (ref)                                                      1.00 (ref)
   Overweight, 25---29.9            1,363   35 (3%)                    0.89 (0.50--1.60)                                                                   1.04 (0.58--1.87)                                               1.05 (0.58--1.91)
   Obese, 30--39.9                  1,731   39 (2%)                    1.93 (0.92--4.02)                                                                   1.99 (0.95--4.19)                                               1.81 (0.85--3.86)
   Morbidly obese, ≥4 0.0           376     13 (3%)                    0.97 (0.54--1.76)                                                                   1.14 (0.62--2.08)                                               1.20 (0.65--2.22)
  Deyo-Charlson index                                                  p = 0.05                                                                            p = 0.08                                                        p = 0.08
   0                                2,086   46 (2%)                    1.00 (ref)                                                                          1.00 (ref)                                                      1.00 (ref)
   1                                836     19 (2%)                    1.07 (0.63--1.83)                                                                   1.07 (0.62--1.83)                                               1.08 (0.62--1.87)
   2                                470     15 (3%)                    1.56 (0.87--2.80)                                                                   1.53 (0.85--2.75)                                               1.56 (0.85--2.85)
   3+                               698     24 (3%)                    1.94 (1.18--3.18)                                                                   1.87 (1.13--3.12)                                               1.92 (1.13--3.26)
  Previous cardiac event                                               p = 0.9                                                                                                                                             p = 0.5
   No                               3,490   91 (3%)                    1.00 (ref)                                                                                                                                          1.00 (ref)
   Yes                              600     13 (2%)                    1.05 (0.59--1.88)                                                                                                                                   0.82 (0.43--1.56)
  Previous thromboembolism                                             p = 0.08                                                                            p = 0.3                                                         p = 0.3
   No                               3,873   97 (3%)                    1.00 (ref)                                                                          1.00 (ref)                                                      1.00 (ref)
   Yes                              217     7 (3%)                     1.97 (0.91--4.26)                                                                   1.50 (0.69--3.29)                                               1.51 (0.69--3.33)
  Operative diagnosis (revision)                                       p = 0.001           p = 0.001                                                       p = 0.003                                                       p = 0.004
   Failure: Loose/wear/osteolysis   2,154   48 (2%)                    1.00 (ref)          1.00 (ref)                                                      1.00 (ref)                                                      1.00 (ref)
   Failure: Previous surgery        801     29 (4%)                    2.12 (1.34--3.37)   2.12 (1.34--3.37)                                               2.14 (1.33--3.42)                                               2.07 (1.29--3.32)
   Failure: Fracture/dislocation    877     18 (2%)                    1.14 (0.66--1.96)   1.14 (0.66--1.96)                                               1.14 (0.66--1.98)                                               1.13 (0.66--1.96)
   Failure: Nonunion                27      2 (7%)                     4.82 (1.17--19.9)   4.82 (1.17--19.9)                                               4.54 (1.09--18.9)                                               4.46 (1.06--18.7)
   Failure: Infection               228     7 (3%)                     2.88 (1.30--6.40)   2.88 (1.30--6.40)                                               2.67 (1.19--6.00)                                               2.73 (1.21--6.16)
  ASA class                                                            p = 0.4                                                                                                                                             p = 0.7
   1                                50      2 (4%)                     1.00 (ref)                                                                                                                                          1.00 (ref)
   2                                1,869   41 (2%)                    0.63 (0.15--2.62)                                                                                                                                   0.72 (0.17--3.05)
   3                                2,098   60 (3%)                    0.91 (0.22--3.73)                                                                                                                                   0.91 (0.21--3.87)
   4                                61      1 (2%)                     0.82 (0.07--9.06)                                                                                                                                   0.68 (0.06--7.89)

**^a^** Multivariable model 1 was a Cox regression model that considered all significant variables from the univariate analyses with p-value \<0.05 and retained only those significantly associated in the multivariable model by using a backward selection process; the c-statistic of the multivariable model was 0.60

**^b^**Multivariable model 2 was a Cox regression model obtained by retaining all variables from the univariate analyses with p-value \<0.20 and forcing all of them in the model; the c-statistic of the multivariable model was 0.63

**^c^**Multivariable model 3 was a Cox regression model obtained by retaining all variables from the univariate analyses regardless of p-value and forcing all of them in the model; the c-statistic of the multivariable model was 0.64

ASA: American Society of Anesthesiologists; CI: confidence interval; ref: reference category.

In the multivariable-adjusted analyses, we found that diagnosis was significantly associated with the risk of postoperative periprosthetic fracture after primary TKR ([Table 3](#T3){ref-type="table"}). Diagnoses of non-union, infection or previous surgery with components removed were associated with a 4.8-, 2.9- and 2-fold higher risk of fracture, respectively, compared to a diagnosis of loosening, wear, or osteolysis.

Survival free of periprosthetic fractures after primary and revision TKR {#ss10}
------------------------------------------------------------------------

Using Kaplan-Meier survival analyses, we assessed cumulative postoperative periprosthetic fracture rates separately for the primary and revision TKR cohorts ([Figure 1](#F1){ref-type="fig"}). We also performed the fracture rate analysis by age group, which was a significant predictor of fracture-free survival in multivariable-adjusted Cox regression analyses ([Figure 1](#F1){ref-type="fig"}).

![Periprosthetic fracture rate after primary and revision TKA (top panels with error bars represent 95% confidence intervals), stratified further by age group (bottom panels). The number of patients at risk at baseline, 5-, 10-, 15- and 20-years is shown at the bottom of each panel.](ORT-84-170-g001){#F1}

Discussion {#ss11}
==========

An important finding in the present study was that younger age ≤ 60 years) was associated with higher risk of postoperative periprosthetic fractures following primary TKR. Specifically, patients who were 61--70 years old had a 50% lower risk of periprosthetic fracture and those who were 71--80 years old had a 45% lower risk compared to patients who were aged 60 years or less. Age \> 80 years was associated with a similar risk of periprosthetic fracture as age 60 years or younger. This suggested that there was a U-shaped relationship between age and periprosthetic fracture risk. It is reassuring that older patients, who receive the majority of TKRs, have lower---not higher---risk of periprosthetic fracture after TKR. Several possible factors may have contributed to this increased risk. A more active lifestyle in patients and involvement in sports in patients aged less than 60 years may put them at higher risk of trauma than those who are older. Younger patients who undergo primary TKR have associated with higher corticosteroid use and may lead to steroid-induced osteoporosis. Osteoporosis ([@CIT0002], [@CIT0021]), inflammatory arthritis ([@CIT0021], [@CIT0016], [@CIT0017]), and corticosteroid use ([@CIT0022]) are associated with higher risk of periprosthetic fracture. Since TKR is being increasingly performed in patients aged less than 65 years, the increased risk of periprosthetic fracture in younger patients is concerning. Previous research has not examined age as a predictor of periprosthetic fractures following primary TKR, except for one recent study from the Scottish registry ([@CIT0019]), which reported that an age of \> 70 years was associated with higher risk. The exact reason for this discrepancy in findings is unclear, but it may be related to differences in country setting (USA vs. Scotland), to patient characteristics, and to the variables that were adjusted in multivariable analyses in the 2 studies (several in our study but only age, sex, and revision surgery in the Scottish study). Our findings should be replicated/confirmed in future studies.

In patients with revision TKR, diagnoses of non-union, infection and of previous surgery with components removed were significant predictors of postoperative periprosthetic fracture. Compared to patients with loosening/wear/osteolysis, those with previous non-union were almost 5 times more likely to suffer from a postoperative periprosthetic fracture. This is not surprising, since abnormal mechanical stresses associated with non-union may predispose to subsequent periprosthetic fractures. A diagnosis of previous surgery with components removed was associated with twice the risk of periprosthetic fracture compared to loosening, wear, or osteolysis. These patients are some of the most challenging surgical cases due to previous surgical complications, and they may inherently be at higher risk of having postoperative complications in general.

An interesting observation in the present study was the borderline association between comorbidity and periprosthetic fracture risk in primary and revision TKR in multivariable-adjusted model 2 (overall: p = 0.05 and p = 0.08, respectively). A score of 3+ for comorbidities was statistically significant in both primary TKR (HR = 1.7, CI: 1.2--2.4) and revision TKR (HR = 1.9, CI: 1.1--3.1). Additionally, in both primary and revision TKR, a dose effect was seen in hazard ratio with an increasing comorbidity score of 1, 2, and 3+ (HR = 1.2, 1.4, and 1.7 for primary TKR and 1.1, 1.5, and 1.9 for revision TKR). We believe that this association in our study was real and borderline association significance is most likely due to the small number of periprosthetic fractures (\< 200), despite the fact that the study covered a 20-year period.

Our estimates of cumulative incidence of periprosthetic fracture of 1.1% for primary TKR and 2.5% for revision TKR were in the range 0.3--2.5% previously reported for TKR ([@CIT0001], [@CIT0021]), as reviewed by [@CIT0023] and [@CIT0018]. The previous studies differed regarding duration of follow-up ([@CIT0021], [@CIT0001]), which might explain the wide range. Despite the large sample size and long duration of follow-up, we had few patients at 20 years, i.e. 76 primary TKAs and 9 revision TKAs. As can be seen, there was a sharp drop-off in sample size after 15 years of follow-up. Thus, the estimates of fractures at 20 years after TKA should not be over-interpreted, and should be considered to be preliminary.

The strengths of the present study were the inclusion of a large number of fractures to allow robust analyses, inclusion of important modifiable variables (BMI and comorbidity), and the use of prospectively collected data.

The study had several limitations, and our findings should be interpreted with some caution. This was a single-center study at an institution that provides surgical care for referrals from other institutions and also primary orthopedic care to the local population (similar to community-based practices). Despite the large sample size, the number of fractures was in the 100--200 range, which may have meant that the study was underpowered for examination of some associations. To put this in perspective, most previous studies have been limited to \< 20 events, with the exception of the national registry studies ([@CIT0016],[@CIT0017], [@CIT0019]). We included several important variables in the present study, but it is possible that there was residual confounding, as in any cohort study. We lacked a measure of osteoporosis in our database, which is a risk factor for fractures in general and might be a risk factor for periprosthetic fracture. These estimates should be considered to be conservative, since despite systematic prospective follow-up of patients with TKR for prosthetic-joint related complications (including all fractures) by trained registry staff (including obtaining medical records and radiographs from other facilities), loss to follow-up and under-reporting of fractures at non-Mayo facilities is possible.

In conclusion, in this large study of primary and revision TKR, we determined the frequency of postoperative periprosthetic fracture following primary and revision TKR. Younger age was a significant risk factor for periprosthetic fracture after primary TKR. Previous non-union and surgery with components removed were significant risk factors for periprosthetic fracture after revision TKR. These are non-modifiable risk factors. Surgeons and patients can have more informed discussion during the informed consent process in light of these findings.
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